Clinical Trial Update: Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial exploring ROBO1-specific CAR-NK cell therapy for solid tumors in early phase studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ROBO1-specific CAR-NK cells

Snippet

Sponsor: Asclepius Technology Company Group (Suzhou) Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN